Dear Reader,
I need to warn you: SELL Oracle (ORCL) shares today.
Here's why you need to move fast:
- In mid-February, AI startup, Anthropic, released a single product update triggering a stunning $300 billion wipeout across software stocks, including Oracle.
This news came less than two weeks after another prior Anthropic update triggered a $1 trillion-dollar sell off in stocks.
But I think this is just the beginning.
AI is easily the fastest-evolving technology in history...
And any publicly traded technology company that produces a product for your computer or smartphone could be the next victim.
That why I invited my good friend, 40-year pro trader, and longtime CNBC contributor, Jon Najarian to explain exactly how to recalibrate and protect your portfolio before AI takes down another sector of the stock market.
The lightning-fast speed of AI improvements mean you can't wait days or even hours before making critical investing decisions.
Pease don't delay: here's what we recommend you do now.
Be well,
Marc Chaikin
Founder, Chaikin Analytics
P.S. My Power Gauge system switched its rating on Oracle (ORCLE) from BULLISH to NEUTRAL, on October 10th.
Since then, the stock has plummeted as much as 53%
And the Power Gauge currently gives it a VERY BEARISH rating.
But this isn't just an Oracle story. This is a market-wide shift and it's already underway across dozens of stocks.
After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound
Submitted by Leo Miller. Article Posted: 2/27/2026.
Key Points
- Tempus AI’s post-IPO volatility has reset expectations, but Q4 results showed strong organic growth alongside acquisition-fueled gains.
- Management’s 2026 outlook points to a potential full-year adjusted EBITDA inflection, a key milestone for the story.
- The company’s large multimodal dataset and entrenched testing channels may make disruption harder, even as analyst targets trend lower.
- Special Report: [Sponsorship-Ad-6-Format3]
Since going public in mid-2024, shares of healthcare and life-science services company Tempus AI (NASDAQ: TEM) have been on a wild roller coaster. The firm's IPO price was $37. The stock climbed above $85 by February 2025, fell to roughly $50 two months later, then rebounded above $100 by October. Around that time, MarketBeat cautioned investors as Tempus showed multiple signs of overvaluation. The stock now trades near $54 per share, down almost 50% from its all-time high.
Tempus just reported its latest financial results, and the market reacted poorly, sending the shares down about 7% afterward. Still, with shares off so sharply, the company is worth revisiting.
TEM Tops Estimates, Projects Full-Year EBITDA Inflection in 2026
Elon Musk: This Could Turn $100 into $100,000 (Ad)
What if you could shrink your entire wealth journey from decades down to just 24 hours?
Sounds impossible…
But I'll show you how Elon Musk is about to make it a reality.
In Q4 2025, Tempus grew revenue 83% year over year to $367 million, beating estimates. Much of that growth came from acquisitions, which inflated the topline, but organic revenue rose a healthy 33.5%. The company also reported an adjusted loss per share of $0.04, slightly better than the $0.05 loss analysts had expected.
Testing volume in the oncology and hereditary testing businesses increased 29% and 23%, respectively. Sustaining this volume growth is critical: more tests not only drive diagnostic revenue but also feed the company's data and applications revenue over time.
Tempus sells the data generated from its tests to pharmaceutical companies to help improve clinical-trial outcomes. Data and applications revenue rose 25%, a slight deceleration from 26% in the prior quarter. The company's net retention rate was 126% for the full year, meaning customers from 2024 increased their spend by 26% in 2025.
Profitability is improving. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) were $12.9 million, up from -$7.8 million in Q4 2024.
Looking ahead, Tempus expects revenue to grow about 25% in 2026 and forecasts adjusted EBITDA of $65 million. If realized, that would mark the company's first full year of positive adjusted EBITDA.
TEM's Huge 450 Petabyte Dataset: An AI-Disruption Shield
The threat that AI poses to Tempus is not clear-cut. Tempus has amassed roughly 450 petabytes of multimodal data it can use to train its own models — a sizable competitive advantage.
To put that figure in context, data-storage firm Pure Storage (NYSE: PSTG) — which will begin trading under the name Everpure on March 5 — estimates the healthcare sector generates about 450 petabytes of imaging data per year. In other words, Tempus's dataset is roughly equivalent in size to a year's worth of healthcare imaging, which is a staggering amount.
Tempus's head start in accumulating this data is meaningful and expanding. Its dataset has more than tripled since 2022, when it was under 150 petabytes. Much of the data flows from its diagnostics segment, where it performs oncology and hereditary testing: more than 8,500 oncologists and thousands of other physicians regularly order tests, giving Tempus a strong foothold.
Reproducing this training data would require competitors to also perform diagnostic testing — something major AI labs generally do not do and likely aren't inclined to pursue. For many AI developers, attacking software-as-a-service use cases is a more logical route than replicating massive proprietary datasets tied to clinical testing.
Tempus is also developing its own foundational model and has submitted it to pharma giant AstraZeneca (NASDAQ: AZN) for review. That model represents a potential revenue stream the company has not yet fully monetized.
Even After Lowering Targets, Analysts Eye Solid Gains Ahead
The MarketBeat consensus price target for Tempus sits near $79, implying more than 40% upside.
It's worth noting that many analysts haven't updated their targets recently. Among price targets revised or issued after Tempus's earnings release, the average is modestly lower, around $71 — still implying roughly 30% upside.
Overall, Tempus appears to be seeing strong demand for its products, and existing customers are spending more, signaling that the company is delivering value and creating upsell opportunities.
Given the company's growth, improving profitability, and the scale of its proprietary dataset, Tempus shares look positioned for a meaningful rebound — though investors should remain mindful of execution risks and the evolving competitive landscape.
Unmanned Profits: The New Kings of the Modern Battlefield
Submitted by Jeffrey Neal Johnson. Article Posted: 3/6/2026.
Key Points
- AeroVironment's battle-proven loitering munitions have become an essential tool for modern ground forces, driving significant revenue growth.
- Kratos is pioneering the future of air combat with its high-performance, attritable aircraft, designed to serve as a powerful force multiplier.
- Red Cat’s strategic partnerships are rapidly expanding its capabilities into new defense domains, including counter-drone systems and maritime security.
- Special Report: [Sponsorship-Ad-6-Format3]
The 21st-century battlefield looks fundamentally different from how it did just a decade ago. The new calculus of conflict is no longer solely determined by the number of tanks or fighter jets a nation possesses. Strategic dominance is increasingly won through the deployment of sophisticated, cost-effective and often expendable unmanned systems. This technological pivot is evident in recent global conflicts, where swarms of intelligent drones have proven capable of altering the course of battles—delivering precision strikes and valuable intelligence without risking a single human life.
This paradigm shift has created a distinct opportunity for investors. While the broader defense sector has drawn attention, the most direct exposure to this trend is not necessarily within diversified defense conglomerates. Instead, it lies with specialized, pure-play companies whose growth is closely tied to the success of unmanned technology.
AeroVironment: The Battle-Tested Industry Standard
Elon Musk: This Could Turn $100 into $100,000 (Ad)
What if you could shrink your entire wealth journey from decades down to just 24 hours?
Sounds impossible…
But I'll show you how Elon Musk is about to make it a reality.
AeroVironment (NASDAQ: AVAV) has solidified its position as an industry standard in unmanned aerial systems (UAS). With long-standing ties to the U.S. Department of Defense, the company supplies technology considered essential to modern infantry tactics. Its flagship Switchblade family of loitering munitions has become synonymous with the kamikaze-drone concept, delivering precision kinetic effects that have proven effective on front lines in Ukraine and other conflict zones. That real-world success is reflected in the company's financials, with recent quarterly revenue up more than 150% year over year.
Recent stock volatility was tied to headlines about the U.S. Space Force SCAR program. A closer look indicates this is not a lost contract but a strategic renegotiation to establish a firm-fixed-price arrangement for a commercialized product—something that could yield more predictable, stable long-term revenue. In a clear signal of management's confidence, AeroVironment announced a significant expansion of its manufacturing capacity. The expansion is intended to scale production for anticipated large orders and position the company to meet growing demand from the U.S. military and its allies for its proven systems.
Kratos: Building the High-Tech Future of Air Combat
Kratos Defense & Security Solutions (NASDAQ: KTOS) is carving out a niche as a high-tech innovator focused on next-generation unmanned combat aircraft. The company is a market disruptor with a portfolio of high-performance, attritable jets, including the XQ-58A Valkyrie. These systems are designed to fly as loyal wingmen alongside manned fighters—acting as force multipliers by scouting, delivering weapons and drawing enemy fire—at a fraction of the cost of traditional aircraft. That approach addresses the Pentagon's need to generate mass against near-peer adversaries while managing program costs.
That ambitious vision requires significant capital, and investors have taken note: the stock is up over 200% in the past year. The company recently raised more than $1 billion through a public offering. While such financings can create short-term pressure on a share price, this one is best viewed as a strategic move to build capital for scale. The proceeds are earmarked to expand production facilities, accelerate R&D and strengthen the company's balance sheet as it pursues multi-billion-dollar program-of-record contracts. Kratos has also secured orders for advanced counter-drone systems, showing it can address both offensive and defensive aspects of unmanned warfare.
Red Cat: The Agile Disruptor Seizing New Domains
Red Cat Holdings (NASDAQ: RCAT) is a smaller, more agile contender in the drone space, focusing on versatile small UAS for ground forces—such as its Teal 2 system, which provides night-vision capability for individual soldiers. The company has attracted investor interest not only for its drones but for a strategy that integrates advanced third-party capabilities to expand quickly. The stock's year-to-date performance, up over 80%, reflects that enthusiasm.
A key catalyst was a strategic partnership with Allen Control Systems. The collaboration will integrate Allen Control System's Bullfrog AI-powered autonomous weapon station onto Red Cat's platforms. That accomplishes two goals: it propels Red Cat into the rapidly growing Counter-UAS (C-UAS) market, and the initial integration on the company's unmanned surface vessels (USVs) expands Red Cat from a drone-focused firm into a multi-domain technology provider for both air and sea. This pivot significantly increases the company's total addressable market and creates a clear path for growth.
Finding Your Fit in the Drone Sector
Understanding the distinct profiles of these three companies is key to aligning any potential investment with an individual's financial strategy. Each offers a different level of exposure to the unmanned-systems thesis.
- AeroVironment: The Established Leader. With a market capitalization of more than $11 billion, AVAV presents a more mature investment profile. Its growth is tied to proven technology and continued demand for tactical loitering munitions.
- Kratos: The High-Tech Innovator. Valued at more than $15 billion, Kratos offers a higher-growth profile centered on disruptive, next-generation systems. Its upside depends on winning large, long-term government contracts for its attritable aircraft.
- Red Cat: The Agile Disruptor. With a market cap under $2 billion, RCAT represents a higher-risk, higher-reward opportunity. Its smaller revenue base is balanced by the potential for rapid growth as it penetrates markets such as C-UAS and maritime defense.
A Clearer View of the 21st-Century Battlefield
The rise of specialized drone companies reflects a long-term shift in military strategy rather than a fleeting trend. Large defense conglomerates offer stability, but their size can dilute exposure to any single high-growth segment. For investors seeking direct participation in the unmanned-systems revolution, the distinct profiles of AeroVironment, Kratos and Red Cat provide a spectrum of compelling opportunities to access the technology-driven future of the defense industry.
This message is a paid sponsorship for Chaikin Analytics, a third-party advertiser of MarketBeat. Why did I receive this email?.
This ad is sent on behalf of Chaikin Analytics, 201 King Of Prussia Rd., Suite 650, Radnor, PA 19087. If you would like to optout from receiving offers from Chaikin Analytics please click here.
If you have questions about your subscription, please email our South Dakota based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
Copyright 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 N Reid Place #620, Sioux Falls, S.D. 57103. United States..
No comments:
Post a Comment